Oct 2026
Primary feasibility analysis of neoadjuvant chemotherapy with bevacizumab for resectable stage II/IIIA non-squamous non-small cell lung cancer: the NAVAL phase II study.
N. Tsubokawa, Yasuhiro Tsutani, Y. Miyata et al.
· Japanese Journal of Clinical... · 0 citations